Breast Cancer

Fundamentals of Evidence-Based Disease Management

Authors:

I. Craig Henderson

Brand: OUP USA

ISBN: 9780199919987

Print on demand. This item has an extended shipping time. The typical delivery time is 4-8 weeks.

499.20 zł

449.28 zł Save 49.92 zł Tax included

Lowest price within 30 days before promotion: 449.28 zł

Quantity

Available in 4-6 weeks

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

modalities. The single most important fact about breast cancer is the great variation in its natural history and its responsiveness to therapy from one patient to another. The clinician must integrate an assessment of the patients likely course based on clinical and pathological staging and laboratory studies with objective evidence on the benefits of therapy. The primary aim of this book is to provide the clinician with the tools to do just that. Outcomes of clinical trials anddetails about commonly used drug regimens, drug dosage, and the expected side effects are summarized in generous tables and figures. Medical terminology has been defined and descriptions of the evolution in our thinking and understanding of the disease are often given to provide perspective in theinterpretation of evidence from current studies for busy clinicians and trainees alike.

Product Details

Brand OUP USA

Reference 86373

EAN13 9780199919987

ISBN 9780199919987

Data sheet

Publication date: 2015
Issue number: 1
Cover: paperback
Pages count: 256
Dimensions (mm): 156 x 235
Weight (g): 448

1. Epidemiology and Risk Factors for Breast Cancer; 2. Primary and Secondary Prevention of Breast Cancer; 3. Premalignant Changes and In Situ Carcinoma; 4. Natural History of Invasive Breast Cancer; 5. Histology of Breast Cancer; 6. Clinical and Pathological Staging; 7. Molecular Factors as Prognostic/Predictive Tools and Therapeutic Targets; 8. Diagnosis, Work-up, and Follow-up of Breast Cancer Patients; 9. Treatment of the Breast and Regional Lymph Nodes Surgery and Radiation Therapy; 10. Adjuvant Systemic Therapy; 11. Neoadjuvant Therapy and Locally-Advanced or Inflammatory Breast Cancer; 12. Management of Metastatic Disease;